Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 44048 questions Show Answers
To ask the Scottish Government by what date the local democracy review will be concluded.
To ask the Scottish Government what action it is taking to help the construction sector, following reports that 10% of the industry is at risk of failure as a result of the removal of (a) temporary measures introduced under Corporate Insolvency and Governance (CIGA), and (b) financial support schemes.
To ask the Scottish Government what scientific evidence is being used to determine the capacities permitted at football stadiums.
To ask the Scottish Government what its position is on introducing a ban on sending wind turbine blades to landfill.
To ask the Scottish Government whether it plans to update the COVID-19 guidance given the apparent variations in the Delta variant symptoms.
To ask the Scottish Government how many prescriptions for antidepressants have been made in each year since 2007, also broken down by NHS board area.
To ask the Scottish Government what the COVID-19 test result turnaround times have been in the last four weeks, broken down by week.
To ask the Scottish Government what communication it has had with (a) Ferguson Marine and (b) Caledonian Maritime Assets Limited (CMAL) since December 2020 regarding completion dates for (i) MV Glen Sannox and (ii) Hull 802.
To ask the Scottish Government what the timescale is for the implementation group that has been tasked with taking forward the recommendations of the National Review of Eating Disorder Services to carry out its work.
To ask the Scottish Government what plans it has to provide COVID-19 antibody and vaccine immunity tests through NHS Scotland for people with low immunity and health conditions who have received both vaccinations but are at risk of not developing antibodies.